GLP‑1 Watchdog Review: What glp1watchdog.com Does Well and Where It Stops

GLP-1 Watchdog is a consumer research site about online GLP-1 providers. Its about page names Eduard Cristea as founder and publisher and describes the site as an independent research team that tracks FDA enforcement actions, side effects and provider costs.2 The core of the site is a comparison table of 49 provider records, each showing a semaglutide subtotal, a tirzepatide subtotal, consultation or program fees, medication type, any insurance claim, and the date the record was saved.1

Around that table sit provider reviews, a price index, cost and insurance guides, a safety section with FDA alerts and a provider checklist, a cost calculator and a matching quiz.1

The site's best quality is its candor about gaps. The comparison table states "Unknown costs are not free," and a provider with no confirmed price shows "Unknown" or "Price unconfirmed" rather than an estimate.1 On the data page, each record says "A missing fee is unknown, not zero," and fields such as labs, dose increases and pharmacy licensing are marked as not established when the site has not established them.6 For a reader comparing programs, that is more useful than a tidy table of numbers nobody checked.

GLP-1 Watchdog keeps the date of each provider check instead of stamping every record with today's date, and its methodology says a page update date "does not mean all provider terms were reverified."3 Where it has re-read a price separately, it shows that date too: Embody's and SnagRx's prices carry a price check dated October 14, 2026.1 You can see at a glance how old each figure is.

The methodology spells out the difference between a one-month supply, a monthly plan and a prepaid price divided by twelve, and it keeps introductory rates and prepaid-only offers out of the monthly figures.3 It also lists what a headline price may leave out: consultation, labs, dose increases, shipping, membership and renewal charges.3 Its advice before paying is practical: get a written total for your prescribed dose, every required service, the commitment, renewal and cancellation terms.3

Every provider record can be downloaded as CSV or JSON from the data page, so anyone can check the figures or reuse them.6 The price index shows its sample size: as of October 22, 2026, the lowest recorded semaglutide subtotal was $79 a month and the median $179, across 19 records with a numeric price; for tirzepatide, $129 and $273.50, across 16 records.7

The affiliate disclosure says GLP-1 Watchdog may earn a commission when a reader signs up with a provider through its links, names the network it uses (Katalys), and says providers cannot pre-approve or edit its reviews.4 The editorial policy describes its sourcing rules, a medical review step and a corrections process, with an address for reporting errors.5

1. Start with the comparison table on the home page. Filter by medication type, sort by semaglutide or tirzepatide subtotal, and look at the date column before the price column.1
2. Open the data page for the detail. Each record lists consultation terms, state count, clinician description, cancellation notes and what is not yet established.6
3. Read the provider's own source. Each record links to the provider page it came from.1 The methodology says those links show what a provider published, not that every statement was independently verified.3
4. Get the full bill in writing before you pay, using the questions the site lists: amount due today and at renewal, required services, dose pricing and total commitment.1

• Many records have no confirmed price. Of 49 provider records, 19 had a numeric semaglutide price and 16 a numeric tirzepatide price in the price index on October 22, 2026.7 The rest show "Unknown" until the site confirms a figure.
• Prices are partial subtotals, not all-in costs. The site says so itself: recorded subtotals "are not verified all-in costs."1
• Not every record is dated. The data page says 30 records have a recorded date and 19 do not, with dates from August 25 to October 3, 2026.6
• Check which checks were done for a given provider. The editorial policy describes pharmacy license and clinician credential checks for provider reviews.5 The structured data page marks pharmacy licensing as "Not independently established in this dataset" and FDA warning-letter status as not established by the record.6 Read the individual review to see what was checked for that provider.
• Some pages are older than others. The about page banner mentions 35 programs, while the home page and data page show 49 records.2,1 The dated data pages are the ones to rely on.
• It earns commissions. Many "Visit" buttons are affiliate links, and the site says affiliate commissions are its primary revenue source.4
• It is not medical advice. The site describes itself as educational information only and tells readers to consult a qualified healthcare provider before starting any medication.1

Many of the providers GLP-1 Watchdog lists sell compounded semaglutide or tirzepatide. Compounded GLP-1s are prepared by a pharmacy to a prescription, and they are not FDA-approved: the FDA doesn't review their safety, effectiveness or quality before they're sold.8

The two sites overlap, and they answer slightly different questions. GLP-1 Watchdog is strongest as a wide, dated record of what 49 providers publish, with every gap labeled. glp1.health covers fewer programs in more depth. Each glp1.health review carries a glp1.health Score with its breakdown and confidence level, checks the program against FDA warning letters, and cites every claim to a numbered source. Our /best rankings and /compare table price each program with its membership fees included, and the glp1.health price index sets the list price of every semaglutide and tirzepatide product beside its cash price, with a free CSV.

Used together, GLP-1 Watchdog is a good place to see which providers exist and what each one has or has not disclosed, and glp1.health is a place to compare the programs we score on a single all-in monthly price. Whichever site you use, confirm the price and terms on the provider's own checkout page before you pay.

Is GLP-1 Watchdog legit? GLP-1 Watchdog is a named publication: its about page names its founder, and it publishes a methodology, an editorial policy, an affiliate disclosure and a corrections address.2,3,4,5 It labels what it has not verified, so read each record's date and notes before relying on a figure.

Is GLP-1 Watchdog free? Yes. The site is free to use; it earns affiliate commissions when readers sign up with some providers through its links, at no extra cost to the reader, according to its disclosure.4

How does GLP-1 Watchdog make money? Mainly through affiliate commissions from providers, through the Katalys network; its disclosure says it may also show display advertising.4

Who runs GLP-1 Watchdog? Its about page names Eduard Cristea as founder and publisher.2

Does GLP-1 Watchdog give medical advice? No. It describes itself as educational information only and tells readers to consult a qualified healthcare provider before starting any medication.1

This article is for information only and is not medical or financial advice. Details about GLP-1 Watchdog were read from its own pages on October 22, 2026 and may have changed. Talk to a licensed clinician about whether a GLP-1 is right for you, and confirm the price and terms with the provider before you pay.